GB9217475D0 - Nauroprotective use cck antagonists - Google Patents
Nauroprotective use cck antagonistsInfo
- Publication number
- GB9217475D0 GB9217475D0 GB929217475A GB9217475A GB9217475D0 GB 9217475 D0 GB9217475 D0 GB 9217475D0 GB 929217475 A GB929217475 A GB 929217475A GB 9217475 A GB9217475 A GB 9217475A GB 9217475 D0 GB9217475 D0 GB 9217475D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- nauroprotective
- cck antagonists
- use cck
- antagonists
- nauroprotective use
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000005557 antagonist Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB919117852A GB9117852D0 (en) | 1991-08-19 | 1991-08-19 | Therapeutic agents |
Publications (2)
Publication Number | Publication Date |
---|---|
GB9217475D0 true GB9217475D0 (en) | 1992-09-30 |
GB2259013A GB2259013A (en) | 1993-03-03 |
Family
ID=10700185
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB919117852A Pending GB9117852D0 (en) | 1991-08-19 | 1991-08-19 | Therapeutic agents |
GB9217475A Withdrawn GB2259013A (en) | 1991-08-19 | 1992-08-17 | Neuroprotective use of CCK antagonists |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB919117852A Pending GB9117852D0 (en) | 1991-08-19 | 1991-08-19 | Therapeutic agents |
Country Status (1)
Country | Link |
---|---|
GB (2) | GB9117852D0 (en) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5554644A (en) * | 1994-06-08 | 1996-09-10 | Warner-Lambert Company | Tachykinin (NK2) antagonists |
US7160880B1 (en) | 1999-05-14 | 2007-01-09 | Cenes Limited | Short-acting benzodiazepines |
CA2657347C (en) | 2006-07-10 | 2014-11-18 | Paion Uk Limited | Short-acting benzodiazepine salts and their polymorphic forms |
WO2008141081A1 (en) | 2007-05-10 | 2008-11-20 | Amr Technology, Inc. | Aryl- and heteroaryl-substituted tetrahydrobenzo-1,4-diazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin |
EP2450039A1 (en) | 2010-11-08 | 2012-05-09 | PAION UK Ltd. | Dosing regimen for sedation with CNS 7056 (Remimazolam) |
AR084070A1 (en) | 2010-12-02 | 2013-04-17 | Constellation Pharmaceuticals Inc | BROMODOMINIUM INHIBITORS AND USES OF THE SAME |
US9249161B2 (en) | 2010-12-02 | 2016-02-02 | Constellation Pharmaceuticals, Inc. | Bromodomain inhibitors and uses thereof |
US9422292B2 (en) | 2011-05-04 | 2016-08-23 | Constellation Pharmaceuticals, Inc. | Bromodomain inhibitors and uses thereof |
EP2721031B1 (en) | 2011-06-17 | 2016-01-20 | Constellation Pharmaceuticals, Inc. | Bromodomain inhibitors and uses thereof |
TWI602820B (en) | 2012-06-06 | 2017-10-21 | 星宿藥物公司 | Bromodomain inhibitors and uses thereof |
EP2864336B1 (en) | 2012-06-06 | 2016-11-23 | Constellation Pharmaceuticals, Inc. | Benzo[b]isoxazoloazepine bromodomain inhibitors and uses thereof |
AR094963A1 (en) | 2013-03-04 | 2015-09-09 | Ono Pharmaceutical Co | EXCELLENT OXIDATION REACTION IN THE CONVERSION INDEX |
EP3157928B1 (en) | 2014-06-20 | 2019-02-13 | Constellation Pharmaceuticals, Inc. | Crystalline forms of 2-((4s)-6-(4-chlorophenyl)-1-methyl-4h-benzo[c]isoxazolo[4,5-e]azepin-4-yl)acetamide |
GB201506448D0 (en) | 2015-04-16 | 2015-06-03 | Univ Durham | An antimicrobial compound |
US10881667B2 (en) * | 2018-10-30 | 2021-01-05 | City University Of Hong Kong | Method and composition for treating epilepsy |
CA3220039A1 (en) | 2021-06-14 | 2022-12-22 | Jr. David St. Jean | Urea derivatives which can be used to treat cancer |
-
1991
- 1991-08-19 GB GB919117852A patent/GB9117852D0/en active Pending
-
1992
- 1992-08-17 GB GB9217475A patent/GB2259013A/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
GB2259013A (en) | 1993-03-03 |
GB9117852D0 (en) | 1991-10-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HU9301603D0 (en) | Angiotensine 11 antagonists | |
HU913074D0 (en) | Fibrinogenic receptor antagonists | |
ZA92600B (en) | Lhrh antagonists | |
PH31071A (en) | Substituted pyrridopyrimidines useful antgiotensinII antagonists. | |
DE69211247D1 (en) | Ellipsometer | |
BG95816A (en) | New sulphonylcarbamides | |
GB9217475D0 (en) | Nauroprotective use cck antagonists | |
EP0574530A4 (en) | Endothelin antagonists | |
GB2246992B (en) | Gangway | |
ZA911111B (en) | Leukotriene antagonists | |
HU9503191D0 (en) | Adhesion-receptor antagonists | |
GB9127041D0 (en) | New use | |
GB9114397D0 (en) | Multi-purpose hitchlock | |
GB2261684B (en) | Construction component | |
NZ241872A (en) | Substituted oxaspirononane paf antagonists | |
GB9108499D0 (en) | Bowls | |
ZA922586B (en) | Cholecystokinin antagonists | |
GB9101503D0 (en) | New use | |
ZA913604B (en) | Heterocyclic-nmda antagonists | |
GB9106467D0 (en) | Tendons | |
GB9100721D0 (en) | Endothelin antagonists | |
ZA921465B (en) | Anti-thrombin polypeptides | |
IE900033L (en) | Beta-adrenergic antagonists | |
GB9121661D0 (en) | New use | |
GB9104834D0 (en) | New use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |